跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JAMP-BRIMONIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JAMP-BRIMONIDINE
Authorized
STANDARD
JAMP-BRIMONIDINE
Jamp Pharma Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3fe62fc7c721c9e9
Company
Jamp Pharma Corporation
Type
Standard
Approval Details
Approval Id
3fe62fc7c721c9e9
Drug Approval Canada Name
JAMP-BRIMONIDINE
Product Name
JAMP-BRIMONIDINE
Status
Marketed
Status Date
2023-04-11
Original Market Date
2023-04-11
Din
02449226
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:40.04
Atc Original
S01EA05 BRIMONIDINE
Atc Name
s 01 ea 05
Aig Number
0131859001
Company Name
Jamp Pharma Corporation
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Company Detail Path
/organization/jamp-pharma-corporation
Company Information
Pharmaceutical Company Name
Jamp Pharma Corporation
Country Name
Canada
Province Name
British Columbia
City Name
chilliwack,british columbia,country_ca
Address
8065 Aitken Rd
Active Ingredients
BRIMONIDINE TARTRATE
0.2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3fe62fc7c721c9e9
Type
Standard
Back to Health Canada Approvals